At Buena Park Heart Center (BPHC), we are dedicated to excellence in cardiovascular care, with a genuine caring attitude for each patient. Our mission is to serve patients with possible and/or definitive cardiovascular conditions and improve their health and quality of life.
Most Enhanced External Counterpulsation (EECP) patients have documented coronary heart disease by selective coronary angiography. Many of these patients have had previous coronary angioplasty and/or coronary artery bypass grafting surgery, along with optimal medical therapy for angina pectoris and/or heart failure.
Patients travel from around the country to receive this valuable treatment that provides significant acute and long-term relief of angina symptoms and offers significant quality-of-life improvements.
EECP is the only safe and effective noninvasive treatment for patients with coronary heart disease.
EECP is a unique alternative for patients with coronary artery disease who are not candidates for angioplasty with stent (percutaneous coronary intervention) and/or bypass surgery (coronary artery bypass grafting surgery).
EECP is indicated for patients with symptomatic coronary artery disease despite optimal medical therapy or previous angioplasty and/or bypass surgery.
EECP should be offered as primary (initial) therapy for coronary heart disease patients with high risk and low benefit profiles, who are candidates for angioplasty or bypass surgery.
EECP is highly beneficial in those heart patients who have failed revascularization procedures (angioplasty or bypass surgery) or have decided not to have such procedures.
EECP is a low-cost and effective therapy with high patient acceptability as compared to angioplasty with stent or coronary bypass surgery.